Correlation Between Guggenheim Strategic and GRI Bio
Can any of the company-specific risk be diversified away by investing in both Guggenheim Strategic and GRI Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Guggenheim Strategic and GRI Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Guggenheim Strategic Opportunities and GRI Bio, you can compare the effects of market volatilities on Guggenheim Strategic and GRI Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Guggenheim Strategic with a short position of GRI Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Guggenheim Strategic and GRI Bio.
Diversification Opportunities for Guggenheim Strategic and GRI Bio
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Guggenheim and GRI is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Guggenheim Strategic Opportuni and GRI Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GRI Bio and Guggenheim Strategic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Guggenheim Strategic Opportunities are associated (or correlated) with GRI Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GRI Bio has no effect on the direction of Guggenheim Strategic i.e., Guggenheim Strategic and GRI Bio go up and down completely randomly.
Pair Corralation between Guggenheim Strategic and GRI Bio
Considering the 90-day investment horizon Guggenheim Strategic Opportunities is expected to generate 0.07 times more return on investment than GRI Bio. However, Guggenheim Strategic Opportunities is 14.68 times less risky than GRI Bio. It trades about 0.23 of its potential returns per unit of risk. GRI Bio is currently generating about -0.03 per unit of risk. If you would invest 1,394 in Guggenheim Strategic Opportunities on May 7, 2025 and sell it today you would earn a total of 99.00 from holding Guggenheim Strategic Opportunities or generate 7.1% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Guggenheim Strategic Opportuni vs. GRI Bio
Performance |
Timeline |
Guggenheim Strategic |
GRI Bio |
Guggenheim Strategic and GRI Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Guggenheim Strategic and GRI Bio
The main advantage of trading using opposite Guggenheim Strategic and GRI Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Guggenheim Strategic position performs unexpectedly, GRI Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GRI Bio will offset losses from the drop in GRI Bio's long position.The idea behind Guggenheim Strategic Opportunities and GRI Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
GRI Bio vs. Biodexa Pharmaceticals | GRI Bio vs. Clene Inc | GRI Bio vs. Foghorn Therapeutics | GRI Bio vs. Werewolf Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |